LAWSUITS NEWS & LEGAL INFORMATION
$6M Settlement Reached in Zithromax Lawsuit
This is a settlement for the Zithromax SJS lawsuit.
New York, NY:Attorney General Terry Goddard announced today that his Consumer Protection & Advocacy Section in Tucson, along with the offices of eighteen other Attorneys General, settled an investigation into Pfizer's Direct-To-Consumer (DTC) advertising for Zithromax a Pfizer product to treat young children' severe ear infections (pediatric acute otitis media or AOM). In addition to DTC ads, the Attorneys General also reviewed promotional Zithromax materials that Pfizer provided to doctors and other health care professionals.
DTC advertising usually urges consumers to ask their doctors to prescribe a certain drug, and specifically in this case, urged the parents of young children to ask for Zithromax because the children would have to take the antibiotic for fewer days than other antibiotics that treat AOM. The Attorneys General alleged that Pfizer' advertisements misrepresented the efficacy of Zithromax in comparison to other antibiotics used to treat AOM by focusing only on Zithromax' dosing convenience and reduced frequency of use. Pfizer failed to disclose that doctors must consider various other factors, such as antibiotic resistance, in deciding what antibiotic to prescribe for AOM.
Pfizer is paying the 19 states involved a total of $4 million dollars for costs and attorneys fees. Arizona' share is $127,273. In agreeing to the settlement, Pfizer did not admit any wrongdoing.
In addition to Arizona, the other 18 states involved in the investigation and settlement are Arkansas, California, Connecticut, Florida, Kansas, Maryland, Massachusetts, New Mexico, Nevada, New York, North Carolina, Ohio, Oregon, Pennsylvania, Tennessee, Texas, Vermont, and Wisconsin
Published on Jan-30-13
DTC advertising usually urges consumers to ask their doctors to prescribe a certain drug, and specifically in this case, urged the parents of young children to ask for Zithromax because the children would have to take the antibiotic for fewer days than other antibiotics that treat AOM. The Attorneys General alleged that Pfizer' advertisements misrepresented the efficacy of Zithromax in comparison to other antibiotics used to treat AOM by focusing only on Zithromax' dosing convenience and reduced frequency of use. Pfizer failed to disclose that doctors must consider various other factors, such as antibiotic resistance, in deciding what antibiotic to prescribe for AOM.
Pfizer is paying the 19 states involved a total of $4 million dollars for costs and attorneys fees. Arizona' share is $127,273. In agreeing to the settlement, Pfizer did not admit any wrongdoing.
In addition to Arizona, the other 18 states involved in the investigation and settlement are Arkansas, California, Connecticut, Florida, Kansas, Maryland, Massachusetts, New Mexico, Nevada, New York, North Carolina, Ohio, Oregon, Pennsylvania, Tennessee, Texas, Vermont, and Wisconsin
Legal Help
If you have a similar problem and would like to be contacted by a lawyer at no cost or obligation, please fill in our form.Published on Jan-30-13
READ MORE Consumer Fraud Settlements and Legal News
READ MORE Defective Products Settlements and Legal News
READ MORE Drugs/Medical Settlements and Legal News
READ MORE Personal Injury Settlements and Legal News
READER COMMENTS
debbie
on
No adverse drug for Zithromax I don't understand why they gave my son a shot of 2000mg which was a over dose.at the hospital from a residential doctor,